Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 480,978 |
|
|||||
| News | (1) | ||||||
| Day High | 35.765 | Low High |
|||||
| Day Low | 34.711 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Arvinas Inc | ARVN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.82 | -2.33% | 34.41 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 35.31 | 34.711 | 35.765 | 35.25 | 35.23 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,029 | 480,978 | US$ 35.08 | US$ 16,874,495 | - | 13.57 - 53.08 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:51:25 | 1 | US$ 34.48 | USD |
Arvinas Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.4B | 68.08M | - | 78.5M | -367.3M | -5.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arvinas News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 31.97 | 37.38 | 31.40 | 34.84 | 889,125 | 2.44 | 7.63% |
| 1 Month | 31.73 | 37.38 | 31.04 | 33.04 | 744,511 | 2.68 | 8.45% |
| 3 Months | 46.90 | 51.51 | 30.91 | 38.02 | 714,423 | -12.49 | -26.63% |
| 6 Months | 21.58 | 53.08 | 21.58 | 38.33 | 804,674 | 12.83 | 59.45% |
| 1 Year | 23.53 | 53.08 | 13.57 | 32.52 | 629,871 | 10.88 | 46.24% |
| 3 Years | 66.63 | 108.465 | 13.57 | 46.83 | 513,954 | -32.22 | -48.36% |
| 5 Years | 22.26 | 108.465 | 13.57 | 46.78 | 498,079 | 12.15 | 54.58% |
Arvinas Description
| Arvinas Inc is a United States-based private biopharmaceutical company focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. Its pipeline candidates include metastatic castration-resistant prostate cancer, metastatic ER-breast cancer, additional oncology indications, tauopathies, and other neurodegenerative diseases. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766. |
